Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Herpes zoster
Influenza
All age groups
Older adults
Western Pacific
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(26)
Topics
Available to download in languages
Regions
Western Pacific
(27)
Africa
(19)
Americas
(18)
Eastern Mediterranean
(6)
Europe
(20)
South-East Asia
(3)
Countries
Australia
(1)
China
(23)
Japan
(1)
Diseases
COVID-19
(22)
Herpes zoster
(1)
Influenza
(4)
Haemophilus influenzae type B
(1)
Hepatitis A
(1)
Hepatitis B
(4)
Human papillomavirus (HPV)
(4)
Mumps
(1)
Pertussis
(2)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rabies
(1)
Rotavirus
(1)
Varicella
(1)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Economic aspects
(4)
Efficacy/effectiveness
(4)
Logistics
(1)
Target population
All age groups
(17)
Older adults
(10)
Adolescents
(3)
Adults
(15)
Children
(4)
Healthcare workers
(5)
Parents/caregivers
(2)
Pregnant women
(1)
Travellers
(1)
Publication date
2023
(1)
2022
(3)
2021
(6)
2020
(15)
2017
(1)
2013
(1)
27 results found
2023
∙
Wang, Qiang Yang, Liuqing Li, Lan Liu, Chang Jin, Hui Lin, Leesa
Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis
2022
∙
Xu, B. Zhu, Y.
A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine
2022
∙
Chen, Z. Peng, Y. Wu, X. Pang, B. Yang, F. Zheng, W. Liu, C. Zhang, J.
Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis
2022
∙
Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
2021
∙
Cheng, S. Zhao, Y. Wang, F. Chen, Y. Kaminga, A. C. Xu, H.
Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis
2021
∙
Hoang, T. Anh, T. T. T.
Comparison of comorbidities in relation to critical conditions among coronavirus disease 2019 patients: A network meta-analysis
2021
∙
Taniguchi, K. Ikeda, S. Hagiwara, Y. Tsuzuki, D. Klai, M. Sakai, Y. Crawford, B. Nealon, J.
Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta-analysis
2021
∙
Yin, T. Li, Y. Ying, Y. Luo, Z.
Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
2021
∙
Yang, X. Zhao, H. Li, Z. Zhu, A. Ren, M. Geng, M. Li, Y. Qin, Y. Feng, L. Peng, Z. An, Z. Zheng, J. Li, Z. Feng, Z.
Review influenza vaccine effectiveness in mainland china: A systematic review and meta-analysis
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register